Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Halliday

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
Pathogens (Basel, Switzerland)|December 2, 2017
What Is Our Current Understanding of PrP<sup>Sc</sup>-Associated Neurotoxicity and Its Molecular Underpinnings?Daniel Hughes, Mark Halliday
Brain : a Journal of Neurology|June 24, 2017
Reply: Trazodone to change the risk of neurodegeneration: bedside to benchMark Halliday, Giovanna R Mallucci
Neuropathology and Applied Neurobiology|January 6, 2015
Review: Modulating the unfolded protein response to prevent neurodegeneration and enhance memoryMark Halliday, Giovanna R Mallucci
Science (New York, N.Y.)|November 16, 2019
Translating translation in Down syndromeMark Halliday, Giovanna R Mallucci
Neuropharmacology|September 17, 2013
Targeting the unfolded protein response in neurodegeneration: A new approach to therapyMark Halliday, Giovanna R Mallucci
Journal of Neurochemistry|June 24, 2017
Fine-tuning PERK signaling for neuroprotectionMark Halliday, Daniel Hughes, Giovanna R Mallucci
Accident; Analysis and Prevention|September 7, 2002
Bridge strike reduction: optimising the design of markingsTim Horberry, Mark Halliday, Alastair G Gale
International Journal of Surgery Case Reports|November 19, 2011
Castleman's disease-A case reportSwetha Iyer, Muhammad Iqbal Bhatti, Mark Halliday
The Journal of Biological Chemistry|May 27, 2014
Prions: generation and spread versus neurotoxicityMark Halliday, Helois Radford, Giovanna R Mallucci
The American Journal of Pathology|June 7, 2011
Systemic low-dose UVB inhibits CD8 T cells and skin inflammation by alternative and novel mechanismsSabita Rana, Linda Joanne Rogers, Gary Mark Halliday
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Pathogens (Basel, Switzerland)|December 2, 2017
What Is Our Current Understanding of PrP<sup>Sc</sup>-Associated Neurotoxicity and Its Molecular Underpinnings?Daniel Hughes, Mark Halliday
Brain : a Journal of Neurology|June 24, 2017
Reply: Trazodone to change the risk of neurodegeneration: bedside to benchMark Halliday, Giovanna R Mallucci
Neuropathology and Applied Neurobiology|January 6, 2015
Review: Modulating the unfolded protein response to prevent neurodegeneration and enhance memoryMark Halliday, Giovanna R Mallucci
Science (New York, N.Y.)|November 16, 2019
Translating translation in Down syndromeMark Halliday, Giovanna R Mallucci
Neuropharmacology|September 17, 2013
Targeting the unfolded protein response in neurodegeneration: A new approach to therapyMark Halliday, Giovanna R Mallucci
Journal of Neurochemistry|June 24, 2017
Fine-tuning PERK signaling for neuroprotectionMark Halliday, Daniel Hughes, Giovanna R Mallucci
Accident; Analysis and Prevention|September 7, 2002
Bridge strike reduction: optimising the design of markingsTim Horberry, Mark Halliday, Alastair G Gale
International Journal of Surgery Case Reports|November 19, 2011
Castleman's disease-A case reportSwetha Iyer, Muhammad Iqbal Bhatti, Mark Halliday
The Journal of Biological Chemistry|May 27, 2014
Prions: generation and spread versus neurotoxicityMark Halliday, Helois Radford, Giovanna R Mallucci
The American Journal of Pathology|June 7, 2011
Systemic low-dose UVB inhibits CD8 T cells and skin inflammation by alternative and novel mechanismsSabita Rana, Linda Joanne Rogers, Gary Mark Halliday
Pageof 4